EyePoint Pharmaceuticals Inc (NASDAQ:EYPT), a specialty pharmaceutical company, focuses on developing and commercializing products for treating eye diseases.
Read full NASCAR article on Yahoo Sports
Read all NASCAR articles
Home » EyePoint Pharmaceuticals Inc’s Chief Medical Officer Dario Paggiarino Sells 22,913 Shares